IPD
IMPEDIMED LIMITED
$0.0050
0.00%
Market cap
$18M
Turnover
$304,122
Last price
$0.0050
Day change
0.00%
Announcements
12
Range, past year
Open 0.034 · Low 0.003 · Now 0.005 · High 0.059
Open IPD in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
IPD momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
24/100
Wyckoff phase
Accumulation33d
Trend stage
Neutral
1 Day
+0.0%
1 Week
+0.0%
1 Month
+0.0%
1 Year
-86.1%
RSI
48
Avg daily range
14.0%
IMPEDIMED LIMITED scores 24 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 33 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently matching and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -33.3%
- High volatility (ATR 14.0%)
- Risk rating: Very High
- Composite downside risk elevated
IPD announcements
Recent price-sensitive releases.
- 2026-08-27 Appendix 4E Preliminary Final Report
- 2026-07-28 Quarterly Activities Report and Appendix 4C - Jun-2026 Qtr Commitments Test Entity - Fourth Quarter Activity Report | Web Cast | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-06-10 Oversubscribed Share Purchase Plan Successfully Completed
- 2026-06-02 CEO Business Update
- 2026-05-04 ImpediMed announces a successful $15.2 million Capital Raise
- 2026-05-04 Equity Raising Investor Presentation
- 2026-04-30 Trading Halt
More Health Care stocks
Most traded in the same sector.